axicabtagene ciloleucel
daiichi sankyo,gilead
['axi-cel', 'dlbcl', 'cll']
#ash22 rwe axi-cel registry data compared to cit (scholar-1) in age &gt;65
n=1146
survival analysis: n=659 axi-cel vs 406 cit axi-cel population older, more prior lines, more refractory orr, cr and os improved with axi-cel 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??